超声刺激相变造影剂用于大分子跨上皮递送:面向胃肠道药物递送
研究在结直肠腺癌细胞单层模型上评估超声联合相变造影剂(PCCA)促进70 kDa荧光素异硫氰酸酯-葡聚糖跨上皮递送的效果。结果显示PCCA联合超声可实现最高44 ± 15%的跨上皮递送,而假照组递送可忽略;在300–600 kPa范围内,300 kPa递送效率最高,低压力下空化活动更持久可能解释这一现象。
要点
- 超声联合PCCA可使70 kDa葡聚糖跨上皮递送达44 ± 15%,假照组可忽略。
- 在300–600 kPa范围内,300 kPa的递送效率最高。
- 较低压力下30秒超声暴露期间空化活动更持久,可能解释递送效率提升。
核心结论
- 超声刺激相变造影剂可瞬时破坏融合的结直肠腺癌单层并改善大分子模型药物的跨上皮转运,低沸点PCCA可用同一低压力脉冲诱导汽化并提供最大递送。
研究设计与样本
- 体外研究,使用融合的结直肠腺癌细胞单层模型,评估超声联合相变造影剂对70 kDa荧光素异硫氰酸酯-葡聚糖跨上皮递送的影响,并量化不同超声暴露条件下的稳定空化和惯性空化能量。
诊断标准与关键数值
- 超声联合PCCA时70 kDa葡聚糖跨上皮递送最高为44 ± 15%,假照对照组递送可忽略。
- 在测试的稀化压力300–600 kPa范围内,300 kPa时葡聚糖递送效率始终最高。
- 较低压力在30秒超声暴露期间产生更持久的空化活动,可能解释递送效率增强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The gastrointestinal (GI) tract presents a notoriously difficult barrier for macromolecular drug delivery, especially for biologics. Herein, we demonstrate that ultrasound-stimulated phase change contrast agents (PCCAs) can transiently disrupt confluent colorectal adenocarcinoma monolayers and improve the transepithelial transport of a macromolecular model drug. With ultrasound treatment in the presence of PCCAs, we achieved a maximum of 44 ± 15% transepithelial delivery of 70-kDa fluorescein isothiocyanate-dextran, compared with negligible delivery through sham control monolayers. Among all tested rarefactional pressures (300-600 kPa), dextran delivery efficiency was consistently greatest at 300 kPa. To explore this unexpected finding, we quantified stable and inertial cavitation energy generated by various ultrasound exposure conditions. In general, lower pressures resulted in more persistent cavitation activity during the 30-s ultrasound exposures, which may explain the enhanced dextran delivery efficiency. Thus, a unique advantage of using low boiling point PCCAs for this application is that the same low-pressure pulses can be used to induce vaporization and provide maximal delivery.
引用
- Fix SM, Koppolu BP, Novell A, et al. Ultrasound-Stimulated Phase-Change Contrast Agents for Transepithelial Delivery of Macromolecules, Toward Gastrointestinal Drug Delivery. Ultrasound Med Biol. 2019. PMID: 31003709. doi:10.1016/j.ultrasmedbio.2019.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。